Fort Washington Investment Advisors Inc. OH Sells 150 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Fort Washington Investment Advisors Inc. OH lessened its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,380 shares of the financial services provider’s stock after selling 150 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in iShares Biotechnology ETF were worth $711,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Tudor Financial Inc. increased its holdings in iShares Biotechnology ETF by 5.9% during the 4th quarter. Tudor Financial Inc. now owns 2,947 shares of the financial services provider’s stock worth $390,000 after acquiring an additional 165 shares during the period. Ameritas Advisory Services LLC increased its holdings in iShares Biotechnology ETF by 9.4% during the 4th quarter. Ameritas Advisory Services LLC now owns 29,094 shares of the financial services provider’s stock worth $3,847,000 after acquiring an additional 2,508 shares during the period. Mirador Capital Partners LP grew its stake in iShares Biotechnology ETF by 0.6% in the 4th quarter. Mirador Capital Partners LP now owns 29,698 shares of the financial services provider’s stock worth $3,926,000 after buying an additional 187 shares in the last quarter. Clarus Wealth Advisors grew its stake in iShares Biotechnology ETF by 1.4% in the 4th quarter. Clarus Wealth Advisors now owns 11,383 shares of the financial services provider’s stock worth $1,526,000 after buying an additional 161 shares in the last quarter. Finally, Pines Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $317,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $138.25 on Friday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The firm has a 50 day simple moving average of $135.97 and a two-hundred day simple moving average of $141.78.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.